Dnl593

1 trials

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

0 Recruiting

1 Completed trials

1 Sponsors

7 Countries

Phase I (FiH)

Phase I (FiH): 1

Oversight events:

6 temporary halts across 1 trial

View oversight register →

Indications tested

Frontotemporal dementia 1

Sponsors using this IMP

Denali Therapeutics Inc. 1

All trials

1 total

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL593 in Healthy Participants and Participants with… Ended

2023-508697-28-00 Phase I (FiH) 7 countries Denali Therapeutics Inc.

Showing 1–1 of 1 trials

← All drugs A–Z